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Uterine gene-expression profiling at the onset of labor <p>A time course of gene expression at the onset of labor reveals transcriptional networks associated with activation of the uterine muscle  and identifies targets for drugs to prevent premature labor.</p>
Abstract
Background: Early transition to labor remains a major cause of infant mortality, yet the causes
are largely unknown. Although several marker genes have been identified, little is known about the
underlying global gene expression patterns and pathways that orchestrate these striking changes.
Results: We performed a detailed time-course study of over 9,000 genes in mouse myometrium
at defined physiological states: non-pregnant, mid-gestation, late gestation, and postpartum. This
dataset allowed us to identify distinct patterns of gene expression that correspond to phases of
myometrial 'quiescence', 'term activation', and 'postpartum involution'. Using recently developed
functional mapping tools (HOPACH (hierarchical ordered partitioning and collapsing hybrid) and
GenMAPP 2.0), we have identified new potential transcriptional regulatory gene networks
mediating the transition from quiescence to term activation.
Conclusions: These results implicate the myometrium as an essential regulator of endocrine
hormone (cortisol and progesterone synthesis) and signaling pathways (cyclic AMP and cyclic GMP
stimulation) that direct quiescence via the transcripitional upregulation of both novel and
previously associated regulators. With term activation, we observe the upregulation of cytoskeletal
remodeling mediators (intermediate filaments), cell junctions, transcriptional regulators, and the
coordinate downregulation of negative control checkpoints of smooth muscle contractile signaling.
This analysis provides new evidence of multiple parallel mechanisms of uterine contractile
regulation and presents new putative targets for regulating myometrial transformation and
contraction.
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Background
The initiation of mammalian labor is a complex physiological
process that requires the expression and secretion of many
factors, both maternal and fetal [1,2]. The majority of these
factors exert their effect on the myometrium, the smooth
muscle responsible for expelling the fetus from the uterus.
While species differences in labor regulation have been
observed, several common signaling pathways and factors
have been implicated as key regulators across species. During
mid to late gestation, myometrial quiescence is maintained by
several contractile inhibitors, such as relaxin, adrenomedul-
lin, nitric oxide, prostacyclin and progesterone [1,2]. A
number of these regulators stimulate cyclic AMP (cAMP)-
and cGMP-mediated signaling pathways. Smooth muscle
contraction is inhibited by the phosphorylation of myosin
light-chain kinase by the cAMP-dependent protein kinase.
This inhibition is believed to promote quiescence. In addi-
tion, the myometrium undergoes major structural changes
throughout pregnancy that are required to generate the nec-
essary contractile force for labor, including hypertrophy and
hyperplasia of smooth muscle, connective tissue, focal adhe-
sion, and cytoskeletal remodeling [3].
The transition to labor results in synchronous contractions of
high amplitude and high frequency by the myometrium. Fac-
tors previously associated with the regulation of myometrial
activation include the oxytocin receptor, gap junction protein
connexin-43, voltage-gated calcium channels, prostaglandin
receptor subtypes, estrogen, cortisol and transcription factors
c-Jun and c-Fos. Most of these proteins participate in path-
ways that stimulate calcium release (for example, calcium-
calmodulin G protein signaling) and the formation of intrac-
ellular junctions, leading to stimulation of contractions.
Although several important components that regulate the ini-
tiation of labor have been identified, the mechanisms that
guide this transition are poorly understood.
A difficult challenge in identifying the regulatory events that
control the switch from myometrial quiescence to activation
has been developing tools for examining whole-genome
expression profiles in the context of known biology. Recent
efforts to identify transcriptional changes from laboring and
non-laboring human myometrium have proved valuable in
identifying putative physiological regulators [4-8]; however,
the lack of gestational time points examined has limited these
approaches to interrogating only those genes with large fold-
changes at term activation without exploring the global pat-
terns of gene expression over the time-course of myometrial
transformation. While gene profiling of the rodent uterus
during gestation has proved fruitful in revealing some of the
large-scale patterns of gene expression throughput pregnancy
[5,9], there is still a critical need to improve the global view of
myometrial gene expression with greater temporal resolution
using newly developed bioinformatic tools.
To identify molecular mechanisms involved in the transition
f r o m  m y o m e t r i a l  q u i e s c e n c e  t o  l a b o r ,  w e  a n a l y z e d  g e n e -
expression changes in mouse myometrium at mid-gestation,
throughout late gestation, and during the postpartum period.
Our results reveal several novel patterns of expression occur-
ring along the phases of myometrial quiescence to term acti-
vation and postpartum involution. Analysis of putative
quiescence and term activation regulators in the context of
well defined biological pathways revealed new putative func-
tional roles for several previously unassociated genes in the
suppression of contraction throughout gestation and activa-
tion of phase-dependent contractions at labor. This analysis
further implicates the regulation of several novel pathways,
including smooth muscle-extracellular matrix interactions
throughout late gestation and cell junction-cytoskeletal inter-
actions immediately before the onset of labor.
Results
Clustering of expression changes in gestational 
myometrium
Messenger RNA transcript levels were measured from iso-
lated myometrium of 35 time-mated mice at four time-points
of late gestation (14.5-18.5 days), at postpartum (6 and 24
hours after labor), and from a non-pregnant control group. In
all, approximately 13,000 probe sets corresponding to
around 9,000 unique cDNAs and expressed sequence tags
(ESTs) were probed with oligonucleotide microarrays. About
35% of these transcripts were regulated throughout gestation
and postpartum (14.5 days through 24 hours postpartum)
using the criteria of p < 0.05 and a change in level of expres-
sion of more than 20% (fold-change 0.2).
Clustering of myometrial expression profiles with HOPACH Figure 1 (see following page)
Clustering of myometrial expression profiles with HOPACH. Gene-expression profiles for 27 microarrays (vertical axis) and 4,510 probe sets (horizontal 
axis) are shown in the context of the HOPACH cluster map (non-pregnant data excluded). The array groups correspond to mid to late gestation (14.5, 
16.5, 17.5 and 18.5 days) and postpartum (6 and 24 h). Eight clusters of genes are arranged vertically. Physiological phase groups are assigned on the basis 
of visual observation and association with previously associated regulators. MAPPFinder results are shown for the top-ranking distinct biological process, 
molecular function and cellular component groups based on a permuted p-value. Previously associated regulators of uterine quiescence and activation are 
indicated by a colored line next to the location of the corresponding gene probe set in the cluster map.http://genomebiology.com/2005/6/2/R12 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. R12.3
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Genome Biology 2005, 6:R12
Figure 1 (see legend on previous page)
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Calb3
Serca2
Kcnmb1
Ryr3
Agtr2
Csh1
Hpgd
Atf2
Cx26
Cx43
Hsp70
Pla2
Ptgs1
Hsd11b1
Scgb1a1
Gnas
Adm
Ana2
Hsd11b2
Calca
Cnn1
Jun
Ptgfr
Gestation Post
cytosolic ribosome (sensu Eukarya)
structural constituent of ribosome
cation transporter activity
muscle contraction
heat shock protein activity
antigen binding
nucleolus
NADH dehydrogenase (ubiquinone) activity
proton transport
muscle development
eukaryotic translation elongation factor 1 complex
chromatin assembly/disassembly
nucleus
primary active transporter activity
viral nucleocapsid
RNA processing
RNA binding
proteasome complex
ubiquitin-dependent protein catabolism
cytoplasmic microtubule
motor activity
protein binding
12/24
19/53
4/7
8/53
52/683
9/43
10/53
4/14
15/122
6/26
metalloendopeptidase activity
ubiquitin-dependent protein catabolism
transcriptional repressor activity
apoptosis
guanyl-nucleotide exchange factor activity
9/32
106/1279
17/120
5/15
12/75
23/201
33/39
56/105
24/97
12/38
8/24
7/21
10/41
5/11
9/33
11/49
3/4
lysosome
MHC class I receptor activity
hydrolase activity\, acting on glycosyl bonds
Golgi apparatus
catalytic activity
coated pit
peptidase activity
glucose catabolism
25/52
6/8
16/51
28/136
220/1963
7/20
43/276
9/31
cell junction
endopeptidase inhibitor activity
protein targeting
amine biosynthesis
structural constituent of cytoskeleton
8/35
6/63
6/65
3/24
6/74
cell growth
extracellular matrix structural constituent
calcium-dependent phospholipid binding
protein-lysine 6-oxidase activity
phospholipase A2 inhibitor activity
calcium ion binding
13/32
15/42
6/10
3/3
3/3
41/233
muscle development
muscle contraction
collagen
structural constituent of cytoskeleton
defense/immunity protein activity
isomerase activity
12/49
10/38
6/26
10/74
8/68
7/61
*
*
*
*
*
*
*
*
*
*
*
*
*
Adjusted permute p < 0.05 Increased term
Increased quiescence
Decreased quiescence
Decreased termR12.4 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. http://genomebiology.com/2005/6/2/R12
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Analysis of these probe sets with HOPACH [10-12] revealed
eight primary cluster groups and 133 subclusters. The major-
ity of these clusters showed a clear association with known
physiological phases of uterine gestation: quiescence (clus-
ters 2, 3, 7 and 8), term activation (cluster 6), and postpartum
involution (clusters 3, 4 and 7). In addition to these clusters,
we observed two cluster groups with genes downregulated or
upregulated throughout the analyzed time-course (clusters 1
and 5) (Figure 1).
MAPPFinder analysis
To characterize the major biological processes, molecular
functions, and cellular components associated with the
HOPACH pattern groups, we used MAPPFinder (a compo-
nent of GenMAPP version 2.0) [13-16]. MAPPFinder pro-
duced a statistically ranked list (based on p-value) of Gene
Ontology (GO) biological categories associated with each
cluster, from which the most significant nonsynonymous
groups are listed (Figure 1, GO categories). In each cluster,
several highly significant biological associations were identi-
fied (adjusted permutation p < 0.05).
Association of expression clusters with previously 
associated uterine quiescence and activation genes
Gene expression groups associated with the maintenance of
pregnancy (quiescence) or induction of labor (activation)
were confirmed by mapping lists of previously associated reg-
ulators of uterine quiescence and activation onto our
HOPACH cluster map. Extensive literature searches for such
regulators identified 66 genes, of which 23 were regulated in
our dataset (Figure 1, previously associated regulators).
Genes hypothesized to regulate quiescence by transcriptional
upregulation or secretion were largely associated with clus-
ters 7 and 8 ('increased quiescence'), while putative activators
of uterine activation were largely associated with cluster 6
('increased term activation'). Although only three downregu-
lated quiescence regulators were associated with HOPACH
clusters, two of them mapped to cluster 2 ('decreased quies-
cence'), as predicted.
Functional analysis of quiescence and term activation 
pattern groups
To further elucidate specific genes and pathways linked to the
regulation of uterine quiescence and the initiation of labor,
we examined pattern groups linked to quiescence and term
activation, in the context of GO categories, GenMAPP path-
way maps and literature associations. While low-magnitude
fold-changes have been included within these functional
analyses to broaden our survey of biological groups, we have
largely restricted our discussion to transcripts with fold-
changes greater than two.
Upregulation of pathways of relaxation and remodeling 
during quiescence
Analysis of genes upregulated throughout gestation
(increased quiescence) revealed a number of biological cate-
gories associated with uterine quiescence. These categories
contain a large number of highly regulated genes coupled to
the inhibition of prostaglandin and cortisol synthesis, stimu-
lation of cAMP and cGMP signaling pathways, extracellular
matrix remodeling, cytolysis and regulation of cell growth
(Figure 2, Table 1). To explore the potential relationships
between the products of these transcriptionally regulated
genes, we mapped the data onto respective metabolic and sig-
naling pathways (Figure 3a,b).
Besides well established quiescence regulators (Adm, Cgrp,
Hsd11b2, Gnas, Cnn1 and Utg; see Tables 1, 2, 3 for full gene
names), several genes previously unassociated with the main-
tenance of quiescence were identified along the same or
related biological pathways. The most highly regulated of
these genes were those implicated in the induction of cGMP
and cAMP signaling pathways (Guca2b and Cmkor1), genes
for calcium-dependent phospholipid binding proteins
(Anxa1, Anxa2, Anxa3 and Anxa8), and for the Anxa2 dimer-
ization partner S100A10 (Figure 3a). Other changes in
expression from this pattern group were observed among
cytolysis-inducing proteases (granzymes B-G), regulators of
cell growth (Igfbp2 and Il1r2), and transcriptional regulation
(Sfrp4 and Klf4). Several of these and other genes were found
to have highly reproducible patterns of expression using
quantitative real-time PCR (TaqMan), with typically larger
fold-changes produced by TaqMan than by GeneChip (con-
sistent with the more conservative fold-changes typically pro-
duced after robust multi-array average (RMA) normalization)
(see Additional data file 1).
Several genes for cAMP-response element transcription fac-
tors were also found within the increased quiescence group
(Atf4, Crebl1, and Creb3, see Figure 3b). These are all mem-
bers of a larger group of basic leucine zipper (bZip)
transcription factors not previously associated with quies-
cence, which also includes the CCAAT/enhancer binding pro-
tein Cebpd, the Maf protein Mafk, the nuclear factor,
interleukin-3, regulated Nfil3, and the X-box binding protein
Xbp1, also upregulated with quiescence.
Downregulation of mRNA processing and contraction-
associated signaling during quiescence
MAPPFinder analysis of genes in the decreased quiescence
group identified a wide variety of cell maintenance, transcrip-
tion, and cell-signaling biological processes. Many of these
GO categories were associated with the onset of labor (cal-
cium-ion transport and protein tyrosine phosphatase activ-
ity) or myometrial postpartum involution (programmed cell
death, collagen catabolism and ubiquitin-conjugating
enzyme activity). These results are in accordance with the
inhibition of contraction and suppression of cell death in late
gestation. Unlike term-related biological processes,
categories shared between the decreased quiescence and
'increased postpartum involution' group appear to be largelyhttp://genomebiology.com/2005/6/2/R12 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. R12.5
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Genome Biology 2005, 6:R12
the result of a common transcript expression profile (Figure
1, cluster 3; Figure 2).
Although similar numbers of genes were downregulated or
upregulated with quiescence (approximately 480-520 genes),
very few genes were downregulated more than twofold at 14.5
days of gestation (Table 2). One of the most downregulated
transcripts was the myosin light-chain gene Myl4; the Myl4
protein is the primary target for oxytocin-induced phosphor-
ylation leading to uterine contraction at term. Several addi-
tional putative components of the oxytocin contractile
signaling pathway (calcium-calmodulin signaling pathway)
were also present in this expression group (Iptr1, Ryr3, Plcg1,
and Atp2a2) (Figure 3b). Another large set of coordinately
downregulated genes includes factors involved in RNA
processing. Alternative splicing of putative quiescence and
term activation regulators has been proposed to be a critical
mechanism of the physiological switch to labor [17,18].
Transition from remodeling and relaxation to cell-cell 
signaling and transcriptional regulation with activation 
of the myometrium at term
A large percentage of genes regulated with quiescence contin-
ued to be highly regulated at term. This result emphasizes the
importance of expression changes immediately before labor
to counteract the effects of quiescence. Consistent with the
number of upregulated genes, MAPPFinder analysis of the
increased term activation group identified a smaller set of GO
terms and pathways. Prominent among these were genes
associated with the formation of cell junctions, kinesin com-
plexes and endopeptidase inhibitors. In addition, function-
ally related transcription factors (members of the basic helix-
loop-helix (bHLH) family), ion transport proteins and ion
transport regulators were coordinately upregulated at term.
Within these biological categories, several contractile regula-
tors, both associated and unassociated with parturition, were
highly upregulated. These genes include those for cell
junction proteins (Cx43, Cx26, Ocln, and Dsp), the pulmo-
nary smooth muscle contractile regulator and complement
component C3, the estrogen signaling regulator Hsp70, the
chloride conductance regulator Fxyd3 and the ryanodine
receptor regulator Gsto1 (Table 3). These changes occurred in
concert with the upregulation of signaling molecules, such as
growth factors (Inhba, Inhbb), G-protein signaling
components (Edg2, Gng12) (Figure 3b) and collagen catabo-
lism proteins (Pep4, Mmp7). On the whole, however, this pat-
tern group was dominated by the upregulation of genes
encoding proteins that are largely epithelial-cell specific.
Most prominent among these are the genes for the cytokera-
tin intermediate filament proteins, Krt2-7, Krt2-8, Krt1-18,
and Krt1-19, and for the cytokeratin transcriptional regulator
Elf3, which are among the most highly upregulated genes at
term.
Association of quiescence and term activation pattern groups with biological pathways Figure 2
Association of quiescence and term activation pattern groups with biological pathways. Significant associations to GO classification groups and GenMAPP 
pathways were determined for each of the four expression pattern groups examined: Displayed are representative gene expression patterns for increased 
and decreased quiescence and term activation. (a) increased quiescence (yellow curve), increased activation (red curve); (b) decreased quiescence (green 
curve) and decreased activation (blue curve). GO terms and GenMAPP pathways highlighted by analysis with the program MAPPFinder are indicated by 
italicized blue text. Biological processes identified by literature association are indicated in black text. Parent biological categories are designated by bold 
text.
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Analysis of pathways of uterine smooth muscle contraction Figure 3
Analysis of pathways of uterine smooth muscle contraction. (a) Prostaglandin synthesis and (b) G-protein signaling pathways in the myometrium are 
overlaid with gene-expression color criterion and fold-changes from the program GenMAPP. Interactions suggested by results of this microarray analysis 
are included in these figures. Detailed gene-expression data, statistics and full gene annotations are available on the GenMAPP interactive version of these 
pathways online [40].
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Table 1
Genes upregulated with quiescence
Increased gestation pattern group Gene symbol Fold-change at 14 days
Prostaglandin and cortisol synthesis
Hydroxysteroid 11-beta dehydrogenase 1 Hsd11b1 10.6
Decidual/trophoblast prolactin-related protein Dtprp 6.2
Hydroxysteroid 11-beta dehydrogenase 2 Hsd11b2 3.6
Cytochrome P450, 11a Cyp11a1 2.3
Prostaglandin-endoperoxide synthase 1 Ptgs1 2.0
Phospholipase inhibition
Annexin A8 Anxa8 4.4
Annexin A3 Anxa3 3.1
Uteroglobin Utg 2.7
Calpactin S100a10 2.5
Annexin A1 Anxa1 2.4
Annexin A2 Anxa2 2.1
Proteolysis and peptidolysis
Kidney-derived aspartic protease-like protein Kdap 8.2
CTLA-2-beta Ctla2b 8.1
Cathepsin Z Ctsz 3.1
Dipeptidase 1 Dpep1 3.1
Procollagen C-proteinase enhancer protein Pcolce 2.6
Lipocalin 7 Lcn7 2.6
Serine-type endopeptidases
Granzyme G Gzmg 71.4
Granzyme D Gzmd 45.7
Granzyme F Gzmf 40.2
Granzyme E Gzme 19.8
Granzyme C Gzmc 10.7
RIKEN cDNA 2210021K23 gene 2210021K23Rik 2.9
Cathepsin G Ctsg 2.2
Protease, serine, 11 (Igf binding) Prss11 2.2
Granzyme B Gzmb 2.1
Protease inhibitors
Tissue factor pathway inhibitor 2 Tfpi2 4.2
Serine protease inhibitor 14 Serpinb9e 3.3
Plasma protease C1 inhibitor Serping1 2.7
Extracellular matrix remodeling and cell growth
Regulation of cell growth
Insulin-like growth factor binding protein 2 Igfbp2 12.4
Interleukin 1 receptor, type II Il1r2 5.0
Glucocorticoid-induced leucine zipper Gilz 3.8
Tumor necrosis factor, alpha-induced protein 2 Tnfaip2 3.3
c-Fos induced growth factor Figf 3.2
Related RAS viral (r-ras) oncogene homolog 2 Rras2 3.0
Cysteine rich protein 2 Crip2 2.9
MORF-related gene X Morf4l2 2.6
Epithelial membrane protein 1 Emp1 2.5
Four and a half LIM domains 1 Fhl1 2.3
S100 calcium binding protein A6 (calcyclin) S100a6 2.3
Insulin-like growth factor binding protein 6 Igfbp6 2.1R12.8 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. http://genomebiology.com/2005/6/2/R12
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Downregulation of pathways of calcium mobilization 
and G-protein signaling in term myometrium
HOPACH analysis with a metric that disregarded the direc-
tion of fold-change (see Additional data file 2) revealed a
small number of downregulated genes at term that mirror the
increased term activation group. Among these, we observed
two highly downregulated genes: regulator of G-protein sign-
aling 2 (Rgs2), a potent inactivator of Gαq-GTP bound activ-
ity, and inhibitor of DNA binding 2 (Idb2), a bHLH factor that
heterodimerizes with other HLH proteins to inhibit their
function.  Rgs2  i s  o n e  o f  t h e  m o s t  downregulated genes
throughout the gestation-postpartum time-course, in addi-
tion to being highly expressed in non-pregnant myometrium
and throughout gestation. Additional term-downregulated G-
protein signaling proteins that act to antagonize calcium-cal-
modulin signaling are illustrated in Figure 3b.
Global mechanisms of transcriptional regulation
One of the most prominent observations in this dataset is the
highly significant correlation in the expression and genomic
position of genes for eight serine-type endopeptidases (Gzmb
through Gzmg, Mcpt8 and Ctsg) during the phase of quies-
cence. Genes within this multigene cluster undergo tight
coordinate regulation in response to cell stimulation [19,20].
Examination of this expression cluster group in the context of
genomic position reveals a novel pattern of positional gene
regulation, where relative fold-change in expression
Transforming growth factor, beta 2 Tgfb2 2.0
Integrin-mediated signaling pathway
Secreted phosphoprotein 1 Spp1 17.3
Connective tissue growth factor Ctgf 2.8
Caveolin, caveolae protein Cav 2.5
Ras homolog gene family, member A2 Arha 2.4
Structural constituent of cytoskeleton
Gelsolin Gsn 2.4
Tropomyosin 4 Tpm4 3.1
Tubulin, beta 2 Tubb2 2.2
Extracellular matrix structural constituent
Microfibrillar associated protein 5 Mfap5-pending 6.9
Elastin Eln 3.1
Procollagen, type XI, alpha 1 Col11a1 3.0
Fibromodulin Fmod 2.4
Fibrillin 1 Fbn1 2.3
Procollagen, type V, alpha 2 Col5a2 2.2
Laminin, gamma 1 Lamc1 2.2
Procollagen, type I, alpha 2 Col1a2 2.2
G-protein signaling
Guanylate cyclase activator 2b Guca2b 15.2
Chemokine orphan receptor 1 Cmkor1 5.0
Adrenomedullin Adm 2.0
Guanine nucleotide binding protein, gamma 11 Gng11 2.0
Transcriptional regulation
Secreted frizzled-related sequence protein 4 Sfrp4 4.2
Kruppel-like factor 4 Klf4 3.0
C/EBP delta Cebpd 2.3
Inhibitor of DNA binding 1 Idb1 2.1
X-box binding protein 1 Xbp1 2.0
Kruppel-like factor 2 Klf2 2.0
Only upregulated genes with a relative fold-change of 2 or more versus non-pregnant mice at 14.5 days gestation and linked to biological categories 
highlighted by the expression analysis are shown. Full gene lists can be obtained online (see Additional data file 6).
Table 1 (Continued)
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increases from the peripheral members in the cluster to the
center of the gene cluster (Figure 4a).
To determine whether other gene clusters exhibit a similar
form of positional co-regulation, we developed a program to
identify genomic intervals containing several coexpressed
genes. Searching for regions with three or more members in a
broad genomic interval (500 kilobases (kb)), we identified 11
clusters of genes that are co-localized and co-regulated (the
same HOPACH cluster) [21]. Among these, we were able to
identify at least one other gene cluster that possessed a
genomic pattern of gene expression similar to that of the
granzyme cluster, with genes maximally upregulated postpar-
tum (Figure 4b). These genes, which encode several of the col-
lagen catabolism matrix metalloproteinases, Mmp3, Mmp10,
Mmp12 and Mmp13, are among the most highly upregulated
genes postpartum. Because we do not have data from full
genome arrays, it is difficult to determine if these co-regu-
lated clusters of genes occur more frequently. However, these
co-regulated gene clusters suggest coordinated gene regula-
tion by an unknown mechanism.
Discussion
This time-course analysis provides the first global view of
gene-expression changes in mouse myometrium from uterine
quiescence through the activation of the myometrium before
labor and to its postpartum involution. Examination of mul-
tiple time points, the use of replicates, robust array normali-
zation and powerful clustering tools enabled us to delineate
and characterize unique patterns of gene expression
throughout this physiological process. In addition to parti-
tioning clusters of genes, analysis with the program HOPACH
also provides us with a continuum of expression changes that
reveals an overall transition in the expression of genes from
one cluster group to another (Figure 1). Annotation of these
clusters with GO terms provides a bird's eye view of the major
processes regulating each of these pattern groups. These
Table 2
Genes downregulated with quiescence
Decreased gestation pattern group Gene symbol Fold-change at 14 days
Regulation of cell growth
Myosin light chain, alkali, cardiac atria Myl4 -2.8
N-myc downstream regulated 2 Ndr2 -2.7
Actin, beta, cytoplasmic Actb -2.2
Calmodulin signaling
MARCKS-like protein Mlp -2.2
Proteolysis
Matrix metalloproteinase 3 Mmp3 -2.2
Ion channels
Expressed sequence AW538430 Kctd12 -2.9
Transcriptional regulation
SRY-box containing gene 4 Sox4 -2.9
Homeobox protein Meis2 Mrg1 -2.5
Special AT-rich sequence binding protein 1 Satb1 -2.1
D site albumin promoter binding protein Dbp -2.1
RIKEN cDNA 1110033A15 gene 1110033A15Rik -2.1
Myeloid ecotropic viral integration site 1 Meis1 -2.0
Regulation of alternative splicing
CDC-like kinase Clk -2.1
Only downregulated genes with a relative fold-change of 2 or more versus non-pregnant mice at 14.5 days gestation and linked to biological 
categories highlighted by the expression analysis are shown. Full gene lists can be obtained online (see Additional data file 6).R12.10 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. http://genomebiology.com/2005/6/2/R12
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Table 3
Genes upregulated with term activation
Gene symbol Fold-change at 18 days
Regulation of cell growth
Inhibin beta-B Inhbb 3.1
Inhibin beta-A Inhba 2.2
Cell death
Growth arrest and DNA-damage-inducible 45 γ Gadd45g 3.2
Baculoviral IAP repeat-containing 1a Birc1a 2.1
Clusterin Clu 2.0
Cell junctions
Occludin Ocln 2.8
Gap junction membrane channel protein α1 Cx43 2.8
Desmoplakin Dsp 2.8
G-protein signaling
Lysophosphatidic acid receptor Edg-2 Edg2 2.8
Guanine nucleotide binding protein, γ12 Gng12 2.1
Structural constituent of cytoskeleton
Villin 2 Vil2 3.1
Kinesin complex
Keratin complex 1, acidic, gene 19 Krt1-19 7.8
Keratin complex 2, basic, gene 7 Krt2-7 4.6
Keratin complex 2, basic, gene 8 Krt2-8 4.6
Keratin complex 1, acidic, gene 18 Krt1-18 4.5
Surfactant associated protein D Sftpd 3.4
Metabolism and biosynthetic reactions
Lipoprotein lipase Lpl 4.5
Aldehyde dehydrogenase family 1, subfamily A2 Aldh1a2 3.9
Glutathione S-transferase omega 1 Gsto1 3.7
Branched chain aminotransferase 1, cytosolic Bcat1 3.4
Protein phosphatase 1, regulatory subunit 3C Ppp1r3c 2.2
Carbonic anhydrase 2 Car2 2.1
Proteolysis and peptidolysis
Cytosolic nonspecific dipeptidase 0610010E05Rik 3.2
Transmembrane protease, serine 2 Tmprss2 2.1
Kallikrein 5 Klk5 2.1
Collagen catabolism
Peptidase 4 Pep4 2.3
Matrix metalloproteinase 7 Mmp7 2.2
Proteolysis inhibitors
Complement component 3 C3 4.3
RIKEN cDNA 1600023A02 gene 1600023A02Rik 2.9http://genomebiology.com/2005/6/2/R12 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. R12.11
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results support the hypothesis that mid-to-late gestation is
dominated by changes in the expression of genes related to
cell growth and extracellular-matrix remodeling (cluster 7),
term gestation by changes in the content of cell junctions
(cluster 6), and postpartum by targeted protein degradation,
collagen digestion and apoptosis (clusters 3 and 4). Further-
more, results from genes upregulated throughout gestation
and through postpartum suggest a continual local uterine
immune response throughout this process (cluster 5). To help
visualize the large-scale gene-expression changes in the con-
text of myometrial physiology, we have depicted the data in
an animation (see Additional data file 3) that summarizes our
major findings.
A number of studies emphasize the importance of fetal regu-
lation of the switch from quiescence to term activation, par-
ticularly increased cortisol and estrogen output from the fetal
adrenal gland [1,2]. Interestingly, our studies provide evi-
dence of a dynamic interplay between the myometrium and
the fetus, particularly at the level of cortisol and progesterone
synthesis (Figure 3a). Genes highly upregulated with quies-
cence include Hsd11b, which encodes an enzyme that
converts cortisol to the inactive cortisone, and Cyp11a1,
encoding an enzyme that promotes the synthesis of proges-
terone. Conversely, Hsd11a, coding for an enzyme that cata-
lyzes the synthesis of cortisol, increased expression from 11-
to 18-fold throughout gestation, suggesting that local regula-
tion of cortisol levels are important for myometrial activation.
While we observed the upregulation of the estrogen signaling
regulator Hsp70, with term activation, downstream markers
of estrogen action are among the most highly upregulated
genes with term activation, supporting the role of the fetus in
myometrial activation.
Examination of highly upregulated putative quiescence and
term activation genes revealed several novel changes within
important associated pathways for quiescence and activation
(cAMP and cGMP signaling, calcium and calmodulin signal-
ing and prostaglandin synthesis). Proteins encoded by these
genes include Guca2b (uroguanylin), Anxa3, and Anxa8 with
quiescence, and C3, Edg2, Gsto1 and Fxyd3 during activation
(see Figure 3). These factors may represent novel targets for
controlling the length of gestation. This is evidenced by the
parallel observed upregulation of Guca2b from a recent
microarray analysis of rat uterine gestation, where this factor
has also been proposed to be a crucial regulator of cGMP-
mediated smooth muscle relaxation throughout late preg-
nancy [9,22]. We have validated the expression patterns of a
number of these genes using quantitative real-time PCR (see
Additional data file 1). In addition to the candidates men-
tioned here, a number of other highly upregulated genes,
whose functions have not been elucidated are also found in
these two expression groups (see Additional data file 6).
Although a number of genes upregulated with quiescence or
with term activation can be clearly implicated in the regula-
Extracellular proteinase inhibitor Expi 2.8
Transcriptional regulation
Transcription factors
Myeloblastosis oncogene Myb 2.5
Hairy and enhancer of split 1 Hes1 2.3
E74-like factor 3 Elf3 2.1
Androgen regulation
Kidney androgen regulated protein Kap 33.9
Heat shock protein 4 Hspa4 3.1
Alpha fetoprotein Afp 3.1
Transport
FXYD domain-containing ion transport regulator 3 Fxyd3 2.8
Lipocalin 2 Lcn2 2.5
Lactotransferrin Ltf 2.2
Solute carrier family 16, member 1 Slc16a1 2.1
Fatty acid binding protein 5, epidermal Fabp5 2.0
Only upregulated genes with a relative fold-change of 2 or more versus non-pregnant mice at 18.5 days gestation and linked to biological categories 
highlighted by the expression analysis are shown. Full gene lists can be obtained online (see Additional data file 6).
Table 3 (Continued)
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tion of contractile pathways or uterine growth, several more
groups of genes with little known functional connection to
these processes were coordinately expressed. Highlighted
among these groups are serine endopeptidases (granzymes)
and bZip transcription factors, upregulated during quies-
cence, and endopeptidase inhibitors and bHLH factors,
upregulated with term activation. In addition to its role in
cytolysis, granzyme expression and secretion by T lym-
phocytes has been associated with the breakdown of extracel-
lular matrix proteins in the uterus during pregnancy
[18,23,24]. Interestingly, the upregulation of serine
endopeptidases appears to be antagonized before the onset of
labor by the upregulation of several serine endopeptidase
inhibitors with term activation. A similar antagonistic rela-
tionship may also exist for bHLH factors upregulated at term
with inhibitors of HLH function that are upregulated with
quiescence and become downregulated at term.
Although the myometrium is considered to be relatively
homogeneous, many of the largest changes in gene expres-
sion at term occurred in genes that are not normally associ-
ated with muscle, such as the keratins, tight junction and
desmosome junction proteins. Indeed, altered gene expres-
sion due to changes in cell-type distribution or the invasion of
the myometrium by the decidua and endometrium would not
be distinguished if those changes occur consistently between
gestational myometrium preparations. Further inspection of
the literature reveals that the cytokeratins, which compose
the bulk of this group, are expressed within smooth muscle
and probably function as components of intermediate fila-
ments of the cytoskeleton [25-28]. Furthermore, several com-
ponents of desmosome spot junctions and hemidesmosomes,
which interact with keratin intermediate filaments and the
extracellular matrix to impart tensile strength between cells,
are also upregulated with term activation (see Additional data
file 3). These data suggest that an increase in rigidity-impart-
ing cell junctions and remodeling of the cytoskeleton immedi-
ately before labor may promote coordinate contractions.
However, further studies are needed to determine if cytoker-
atin expression at term occurs within resident or infiltrating
cells.
In addition to the capability to group and annotate clusters of
genes, pattern analysis with HOPACH can be used to interro-
gate gene clusters in the context of genomic location. For this
analysis, we developed a program to isolate gene clusters that
are likely to be co-regulated on the basis of genomic location,
similar to other reported methods [29-32]. Using this pro-
gram, we identified genomic regions that undergo correlated
changes in gene expression associated with specific phases of
the myometrial time-course. These groups highlight novel
forms of gene regulation during quiescence and postpartum
to coordinate cell responses (serine-protease activation and
collagen catabolism). The prominent co-regulation among
members of these two gene clusters further suggests that
immune-cell trafficking and activation also play important
roles in the progression towards labor and recovery from
pregnancy.
Conclusions
We have identified several highly regulated genes not previ-
ously associated with myometrial quiescence or activation, in
addition to families of genes co-regulated at different phases
Association of genomic localization with co-regulation of expression Figure 4
Association of genomic localization with co-regulation of expression. (a,b) Chromosomal gene clusters contain highly correlated expression changes 
among multiple members. Global patterns of gene expression within these genomic intervals are visualized by representing mean log expression for four of 
the myometrium time-point groups (non-pregnant, 14.5 and 18.5 days gestation, and 24 h postpartum), versus relative gene position on the chromosome. 
Gene strand orientation and position is designated by the orientation of arrows. Gene symbols above and below arrows are shown, where italicized black 
text indicates co-regulated genes (same HOPACH cluster) and italicized gray genes not co-regulated for (a) increased quiescence and (b) increased 
postpartum involution. Non-italicized gray text indicates genes not probed by the arrays.
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of the myometrial time-course. In addition to providing new
hypotheses about how the switch from quiescence to term
activation may be facilitated (Figure 5), these data highlight
several proteins that may serve as new candidate pharmaco-
logical targets for regulating myometrial contraction and thus
the onset of labor. Such analyses will also be useful in predict-
ing and correlating gene-expression changes in human preg-
nancy, where several time-points are often difficult to obtain
[4-8]. Similar studies in other species using complementary
methods of transcript measurement will also be necessary to
validate these changes and understand the species-specific
and regional myometrium transcriptional differences that
probably occur. A detailed examination of the precise physio-
logical roles of these regulators and mechanisms of regulation
will be essential for developing a more detailed view of the
regulation of labor.
Materials and methods
Tissue harvesting
FVB/N mice (Jackson Laboratory) were sacrificed in the
morning (10 to noon) at 14.5 (n = 3), 16.5 (n = 4), 17.5 (n = 5),
or 18.5 days (n = 7) after timed mating, and 6 (n = 4) or 24 h
(n = 4) after delivery. Control myometrium was harvested
from non-pregnant littermate females (n  = 8) 1 day after
timed mating with a vasectomized male. After dissection of
both uterine horns, the tissue closest to the cervix was
removed. Each horn was washed with PBS and opened longi-
tudinally. Pups and placenta were discarded, and the decidua
was removed by blunt dissection. The myometrium from each
horn was then immediately frozen in liquid nitrogen and
stored at -80°C.
Sample preparation and microarray data 
normalization
For each sample, labeled cRNA  w as pr ep ar e d fr om 2 0 µg
purified total RNA and hybridized to Affymetrix Mu11k A and
B arrays according to the manufacturer's instructions. Tissue
from each mouse was hybridized individually to one array set.
Microarrays were scanned at a photomultiplier tube (PMT)
setting of 100%. Resulting .cel files were generated with
Affymetrix Microarray Suite 5.0 and analyzed with RMA [33].
Statistical analysis
To identify transcripts differing in mean expression across
the seven experimental groups, p-values were calculated from
a permutation test with the F-statistic function from the mult-
test package of Bioconductor [12,34]. Fold-changes in tran-
script levels were calculated from the mean log2 expression
values of each time-point group versus the mean of non-preg-
Proposed maternal model of uterine-directed contractile regulation Figure 5
Proposed maternal model of uterine-directed contractile regulation. Theoretical model based on the major gene-expression pattern groups for 
quiescence, term activation and postpartum involution (light gray box outline). Arrows next to gene processes and functional groups indicate the 
predominant direction of fold-change as indicated by HOPACH analysis. This model proposes new roles for transcriptional regulators, regulators of 
mRNA processing, local hormone regulation, protease activity and cell junction formation in the control of both contractile signaling and contraction 
propagation in the myometrium during pregnancy. A model of postpartum involution is also presented, based on additional data (see Additional data files 
4-6).
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nant controls. For cluster analysis, the dataset was filtered for
probe sets with a p < 0.05 across the full expression time-
course and a greater than 20% change in level of expression
(positive or negative) for at least one time-point group versus
non-pregnant controls. Additional filters were used down-
stream of clustering for genes related to uterine quiescence
and term activation. For clusters related to quiescence and
term activation, a change of more than 20% was required for
the midgestation (14.5 days) and term (18.5 days) time points,
respectively, versus non-pregnant controls.
Clustering and pattern analysis
Gene expression clustering for 4,510 significant probe sets
was performed using the program HOPACH (hierarchical
ordered partitioning and collapsing hybrid), with uncentered
correlation distance [10-12]. HOPACH produced a tree with
six levels of clusters (eight primary level clusters and 133
main clusters). To examine expression patterns independ-
ently of the direction of the fold change, HOPACH was re-run
with absolute uncentered correlation distance. Associations
with GO biological process, molecular function, cellular com-
ponent groups, and GenMAPP biological pathways were
obtained with MAPPFinder 2.0, a part of the GenMAPP 2.0
application package [13-16]. A permuted p-value was calcu-
lated by MAPPFinder 2.0 to adjust for multiple hypothesis
testing (see Additional data file 7). Because of the highly
redundant nature of the oligonucleotide arrays used, redun-
dant probe sets corresponding to a single gene were identified
from the Affymetrix NetAFFX website [35].
Real-time PCR validation of microarray data
Real-time reverse transcription PCR (RT-PCR) was used to
validate the expression patterns of several highly regulated
genes associated with specific phases of myometrium gesta-
tion. Gene-specific primers for multiplex real-time RT-PCR
were designed for each gene of interest (n = 18) using Primer
Express software (Perkin Elmer) and based on sequencing
data from the National Center for Biotechnology Information
(NCBI) databases and purchased from Biosearch
Technologies. Sequence data for all oligos are available online
[36]. Total RNA concentration and quality was assessed using
the Agilent Bioanalyzer 2001. First-strand cDNA synthesis
was performed using total cellular RNA (BD Biosciences
Clontech), Powerscript reverse transcriptase (BD Biosciences
Clontech), and random hexamer primers. Finally, an equiva-
lent of 10 ng of total RNA from the first-strand cDNA
synthesis reaction was used in 10 µl of each TaqMan gene
quantification in 384-well format. Universal Master Mix for
real-time PCR was purchased from Invitrogen Life Technolo-
gies. Raw data from an ABI Prism 7900 (Applied Biosystems)
were processed into Excel spreadsheets and conversion of
raw Ct values to relative gene copy numbers (GCN) was done
as described previously [37]. Gene-expression analysis
requires proper internal control genes for normalization. By
using an endogenous control as an active reference, quantifi-
cation of an mRNA target can be normalized for differences in
the amount of total RNA added to each reaction. For this pur-
pose, we used four mouse housekeeping genes - PPIA,
GAPDH, PGK1 and S9. Moreover, using GeNorm [38], we
selected PGK1 and GAPDH as the two most stable housekeep-
ing genes across all 12 specimens and used their geometric
means for normalization. Normalized data were graphed and
compared to the data generated on similar specimens via
microarrays. Genes could be broken down into the following
groups: 13 genes with concordant microarray-TaqMan pat-
terns; one false-negative result by microarray (Acta2); three
genes with high TaqMan variability (Mmp9, Krt19, Id1); and
one gene with evidence of alternative splicing (Csb) (see Addi-
tional data file 1). It should be noted that Acta2  baseline
expression was relatively high for both microarray and Taq-
Man results. As both of these techniques probed different
regions of the Acta2 gene, we cannot exclude the possibility of
alternative splicing.
Chromosomal localization analysis
We constructed a program to link HOPACH expression data
to chromosome transcription start-site location and strand
orientation, obtained from the Ensembl database [39]. Co-
localized clusters of genes were identified as those genes clus-
tered within a 500-kb genomic interval, belonging to the
same HOPACH cluster, with a z-score >1.96, and an average
pairwise Pearson correlation among cluster members of r
>0.65 (see Additional data file 7 for calculation details and
[21] for the full supplemental chromosome cluster lists).
Additional data files
The following additional data are available with the online
version of this article. Additional data file 1 is a figure showing
the TaqMan vs GeneChip gene expression patterns. Relative
fold changes (log base 2) are shown for 18 genes identified by
these GeneChip studies to be differentially regulated through-
out the myometrium gestation time-course. Combined
standard errors are shown for each gestational time-point as
compared to the non-pregnant control group. Additional data
file 2 is a figure showing the HOPACH Absolute Value Pear-
son Correlation of Myometrial Expression Data. Gene expres-
sion data used for Pearson correlation HOPACH was used to
generate a new set of clusters with a metric that disregards the
direction of fold-change. Genes downregulated with term are
identified based on association with genes upregulated at
term from the non-absolute HOPACH analysis. Additional
data file 3 is an animation of the summary and results, with a
cartoon representation of myometrial transformation, gen-
eral experimental design, results and conclusions. Additional
data files 4 and 5 are Excel tables listing the MAPPFinder
results. Nonsynonymous MAPPFinder GO categories for each
expression pattern group are provided. Reanalysis with Gen-
MAPP version 2.0 is required to visualize the genes that asso-
ciate with each GO term. To download GenMAPP version 2.0,
go to [16]. Additional data file 6 is a set of tables of cluster
groups with annotations. Expression data, statistics, and bio-http://genomebiology.com/2005/6/2/R12 Genome Biology 2005,     Volume 6, Issue 2, Article R12       Salomonis et al. R12.15
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logical groupings based on Gene Ontology annotations (via
MAPPFinder analysis) and the literature are provided for
'Quiescence', 'Activation', and Postpartum 'Involution' gene
lists. Additional data file 7 contains additional details of
methods. Additional data file 8 contains the full expression
dataset as an Excel file and Additional data file 9 is a
GenMAPP format GEX file for use with GenMAPP format
pathway maps (MAPP files). MAPP files can be downloaded
from [16].
Additional data file 1 A figure showing the TaqMan vs GeneChip gene expression  patterns A figure showing the TaqMan vs GeneChip gene expression  patterns Click here for additional data file Additional data file 2 A figure showing the HOPACH Absolute Value Pearson Correlation  of Myometrial Expression Data A figure showing the HOPACH Absolute Value Pearson Correlation  of Myometrial Expression Data Click here for additional data file Additional data file 3 An animation of the summary and results, with a cartoon represen- tation of myometrial transformation, general experimental design,  results and conclusions An animation of the summary and results, with a cartoon represen- tation of myometrial transformation, general experimental design,  results and conclusions Click here for additional data file Additional data file 4 Excel tables listing the MAPPFinder results: HOPACH unique GO Excel tables listing the MAPPFinder results: HOPACH unique GO Click here for additional data file Additional data file 5 Excel tables listing the MAPPFinder results: MAPPFinder quies- cence, activation and postpartum Excel tables listing the MAPPFinder results: MAPPFinder quies- cence, activation and postpartum Click here for additional data file Additional data file 6 A set of tables of cluster groups with annotations A set of tables of cluster groups with annotations Click here for additional data file Additional data file 7 Additional details of methods Additional details of methods Click here for additional data file Additional data file 8 The full expression dataset as an Excel file The full expression dataset as an Excel file Click here for additional data file Additional data file 9 A GenMAPP format GEX file for use with GenMAPP format path- way maps (MAPP files) A GenMAPP format GEX file for use with GenMAPP format path- way maps (MAPP files) Click here for additional data file
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